Skip to main content

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Agency: National Institutes of Health

Assistance Listings
  • 93.121 -- Oral Diseases and Disorders Research
  • 93.395 -- Cancer Treatment Research

Open opportunityLast Updated: Oct 14, 2026

Important dates

  • Closing: September 25, 2029

Award details

  • Expected project funding: $1,400,000
  • Expected awards: 10

Award min.

Not specified

Award max.

Not specified

  • Funding opportunity number:PAR-28-022
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Grant
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Posted date: October 14, 2026
  • Archive date: November 25, 2029
  • Version: 1

View version history on Grants.gov

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPOREs). Based on the proposed research, applications may be jointly funded with the National Institute of Dental and Craniofacial Research (NIDCR). This is a re-issuance of PAR-23-284. The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a highly related group of cancers. The research supported through this program must be translational and be based on human biology research using cellular, molecular, structural, biochemical, and/or genetic experimental approaches. SPORE projects must reach a translational human endpoint within the project period of the grant. 

Eligibility

Government

  • Federally recognized Native American tribal governments
  • Public and Indian housing authorities
  • State governments
  • County governments
  • City or township governments
  • Special district governments

Nonprofit

  • Other Native American tribal organizations
  • Nonprofits non-higher education without 501(c)(3)
  • Nonprofits non-higher education with 501(c)(3)

Education

  • Public and state institutions of higher education
  • Independent school districts
  • Private institutions of higher education

Business

  • Small businesses
  • For-profit organizations other than small businesses

Miscellaneous

  • Other

Additional information on eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Documents

File nameDescriptionLast updated
PAR-28-022-Full-Announcement.html
PAR-28-022-Full-Announcement.html
Oct 14, 2026 04:18 PM UTC

Agency contact information

Email: NCI_SPORE_Program@nih.gov

Division of Cancer Treatment and Diagnosis/National Cancer Institute

Translational Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI) NCI_SPORE_Program@nih.gov

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov